Kunyu Y. Yang
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 174 publications
Performance evaluation of clinical diagnostic kits for Group B Streptococcus available in China.
Journal: Microbiology spectrum
Published: August 27, 2026
Izalontamab Brengitecan (Iza-Bren), a First-in-Class EGFR-HER3 Bispecific Antibody-Drug Conjugate in Extensive-Stage Small Cell Lung Cancer: Results From a Phase Ib Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 24, 2026
FGF/FGFR Alteration Type as a Candidate Enrichment Biomarker for Gunagratinib in Recurrent or Metastatic Head and Neck Cancer: An Exploratory Analysis of Two Early-Phase Trials.
Journal: Targeted oncology
Published: June 16, 2026
Becotatug vedotin for recurrent/metastatic nasopharyngeal carcinoma (Magic-M001): a multicenter, randomized trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 20, 2026
Should standard concurrent chemoradiotherapy remain the preferred treatment for elderly patients with locoregionally advanced nasopharyngeal carcinoma?
Journal: Radiation oncology (London, England)
Published: March 11, 2026
Correction: Radiated tumor cell-derived microparticles effectively kill stem-like tumor cells by increasing reactive oxygen species.
Journal: Frontiers in bioengineering and biotechnology
Published: January 25, 2026
Postoperative anlotinib plus radiotherapy in patients with newly diagnosed, unmethylated O6-methylguanine-DNA methyltransferase glioblastoma: A single-arm, phase 2 study.
Journal: Cancer
Published: December 03, 2025
Phase Ib Trial of Finotonlimab Combined With SCT200 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Journal: Cancer medicine
Published: November 10, 2025
Efficacy and safety of anti-LAG-3 IBI110 in combination with sintilimab and chemotherapy for advanced squamous non-small cell lung cancer: a randomized phase II study.
Journal: Cancer immunology, immunotherapy : CII
Published: October 30, 2025
Chemoradiotherapy-Integrated Tumor Cell-Derived Microparticles Mediate Tumor Eradication in Malignant Pleural Effusion.
Journal: Journal of extracellular vesicles
Published: October 05, 2025
Expert consensus on the combination of Anti-EGFR monoclonal antibodies and immune checkpoint inhibitors in the treatment of head and neck squamous cell carcinoma.
Journal: Cancer treatment reviews
Published: September 08, 2025
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody-drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China.
Journal: Lancet (London, England)
Published: September 08, 2025
Last Updated: 09/26/2026